Goldman Sachs
ZVSA

Goldman Sachs’s ZyVersa Therapeutics ZVSA Stock Holding History

Goldman Sachs’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-296
Closed -$200K – 6124
2023
Q1 		$200K Buy
296
+112
+61% +$83.8K ﹤0.01% 5304
2022
Q4 		$101K Buy
+184
New +$537K ﹤0.01% 5477

Other funds holding ZVSA

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $7.09B AUM 21.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.22B AUM 17.78% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return